Perhaps coincidently, the lead variant (rs117267808) in the GP2 gene identified in the latest GWAS meta-analysis of T2D in the Japanese population was also identified in our GWAS meta-analysis of pancreatic cancer (Supplementary Table 5). The gene discussed is GP2; the disease is pancreatic neoplasm.